(L) The take-home supply for patients enrolled in an opioid treatment program receiving methadone during the first ninety days of treatment is limited to a single dose each week. The patient shall ingest all other doses under appropriate supervision in accordance with 42 CFR 8.12(i)(3). At the discretion of the medical director or other authorized program physician, a patient may receive one additional take-home dose for those holidays listed in paragraph (N) of this rule if the opioid treatment program is closed in observance of the holiday.(M) The take-home supply for patients enrolled in an opioid treatment program receiving partial opioid agonist during the first ninety days of treatment is limited to a fourteen days' supply. After the first ninety days of treatment, the amount of take-home supply may never exceed one month.(N) Take-home doses of medication for medication assisted treatment shall not be permitted for clients who are on short-term opiate detoxification except on federal holidays and Sundays if the program is closed.(O) If the opioid treatment program is closed for any of the following federal holidays, all patients receiving methadone may be given a one-day take-home dose at the discretion of the medical director.(1) Thanksgiving day.(2) Christmas day.(3) New year's day.(4) Martin Luther King day.(5) President's day(6) Memorial day(7) Fourth of July(8) Labor day(9) Columbus day(10) Veteran's day(P) The opioid treatment program shall have written procedures for take-home medication assisted treatment doses that include:(1) Statement that the opioid treatment program decisions on dispensing take-home doses of medication shall be determined by the medical director or other authorized program physician;(2) Statement that a take-home dose of medication is an earned privilege and not a right;(3) Requirement that take-home doses of medication shall be given only to a patient, who, in the opinion of the medical director or other authorized program physician, is responsible in handling medication;(4) Except during program closure on Sundays and federal holidays listed in paragraph (N) of this rule, a statement that before a medical director or other authorized program physician authorizes take-home doses of medications used for medication assisted treatment, the medical director or other authorized program physician shall record the rationale for this decision in the patient's clinical record and consider, at a minimum, the following criteria:(a) Absence of recent abuse of opioid or other drugs and alcohol;(b) Regularity of clinic attendance for medication administration;(c) Regularity of clinic attendance for counseling sessions;(d) Absence of serious behavioral problems at the clinic;(e) Absence of known recent criminal activity, for example, drug dealing;(f) Stability of the patient's home environment;(g) Stability of the patient's social relationships;(h) Length of time in comprehensive maintenance treatment;(i) Assurance that take-home doses of methadone can be safely stored within the patient's home;(j) Determination if the rehabilitation benefit to the patient by receiving a take-home dose of medication assisted treatment outweighs the potential risks of diversion; and,(k) Employment status of patient.(5) Statement that physician orders for take-home medication for substance use disorders shall expire every ninety days;(6) Requirement that education on the proper safe storage and disposal of take-home medication be provided to patients prior to the first take-home dose.(7) Requirement that child-resistant packaging or caps be used for take-home doses of medications for substance use disorders; and,(a) If a take-home bottle or other form of packaging is returned by a patient for refills, the opioid treatment program shall accept the bottle or other form of packaging and dispose of it.(b) If a take-home bottle or other form of packaging is utilized for take home doses, the medication bottles - shall only be used once.(c) Under no circumstance is medication to be placed in a container provided by a patient (including previous take-home bottle).(8) Requirement that each take-home bottle or other form of medication packaging used for medication assisted treatment dispensed or personally furnished have a label that contains the following information:(a) The opioid treatment program's name, address and telephone number;(b) Name of patient;(c) Name of program physician prescribing the medication;(d) The name of the medication;(e) The dosing instructions and schedule;(f) Date that the take-home dose was prepared;(g) The label shall contain the following warning "Caution: Federal law prohibits the transfer of this drug to any person other than the patient for whom it was prescribed."; and,(h) Any other requirements pursuant to rules adopted by the state board of pharmacy. see full law